10.1002/anie.202107182
Angewandte Chemie International Edition
COMMUNICATION
Aside from the substrate scope of the novel bacterial CHIs, we
investigated the stereoselectivity. Plant-derived CHIs have been
confirmed to have a strict (S)-stereoselectivity.[5] However,
ERED/Fcr can directly reduce (R)-naringenin, which indicates that
bacterial CHIs are probably also able to isomerize (S)-naringenin
to the (R)-isomer through its chalcone in aqueous solution and
form a cascade reaction with ERED/Fcr to convert flavanones to
dihydrochalcones.[9] However, direct evidence of bacterial CHIs
with (R)-stereoselectivity is missing. Stereoselectivity was now
determined using 1a as substrate and mainly (S)-naringenin was
detected in the reaction with a ratio of approx. 9:1 (S:R) for CHIera
and the novel identified bacterial CHIs (CHI1-CHI13, Figure S5a).
Considering to the rapid self-cyclization of chalcones in aqueous
solution to generate racemic flavanones, this optical purity
measurement proved that bacterial CHIs are (S)-selective.
Furthermore, we also determined in this work the stereoselectivity
Keywords: biocatalysis • chalcone • chalcone isomerase •
flavonoid • flavanone
[1]
[2]
M. L. F. Ferreyra, S. P. Rius, P. Casati, Front. Plant Sci. 2012, 3, 222.
B. Romano, E. Pagano, V. Montanaro, A. L. Fortunato, N. Milic, F.
Borrelli, Phytother. Res. 2013, 27, 1588-1596.
[3]
T. Goris, A. Perez-Valero, I. Martinez, D. Yi, L. Fernandez-Calleja, D.
San Leon, U. T. Bornscheuer, P. Magadan-Corpas, F. Lombo, J.
Nogales, Microb. Biotechnol. 2021, 14, 94-110.
[4]
[5]
[6]
R. P. Pandey, P. Parajuli, M. A. G. Koffas, J. K. Sohng, Biotechnol.
Adv. 2016, 34, 634-662.
Y. C. Yin, X. D. Zhang, Z. Q. Gao, T. Hu, Y. Liu, Mol. Biotechnol. 2019,
61, 32-52.
a) J. M. Jez, J. P. Noel, J. Biol. Chem. 2002, 277, 1361-1369; b) J. M.
Jez, M. E. Bowman, R. A. Dixon, J. P. Noel, Nat. Struct. Biol. 2000, 7,
786-791.
[7]
[8]
a) L. Ralston, S. Subramanian, M. Matsuno, O. Yu, Plant Physiol. 2005,
137, 1375-1388; b) N. Shimada, T. Aoki, S. Sato, Y. Nakamura, S.
Tabata, S. Ayabe, Plant Physiol. 2003, 131, 941-951.
a) M. Kaltenbach, J. R. Burke, M. Dindo, A. Pabis, F. S. Munsberg, A.
Rabin, S. C. L. Kamerlin, J. P. Noel, D. S. Tawfik, Nat. Chem. Biol.
2018, 14, 548-555; b) M. N. Ngaki, G. V. Louie, R. N. Philippe, G.
Manning, F. Pojer, M. E. Bowman, L. Li, E. Larsen, E. S. Wurtele, J. P.
Noel, Nature 2012, 485, 530-533.
of the CHI and mutants with the highest activity (CHIera, CHIera
-
Mut5 and CHIera-Mut11) towards 1a–5a (Figure S5b). These three
enzymes presented relatively strict (S)-stereoselectivity towards
1a and 4a, but almost no stereoselectivity for 2a and 3a, which
shows the great influence of the structure and position of the
substituents on the B-ring on the stereoselectivity of the CHIs.
CHIera-Mut11 showed high stereoselectivity (9:1) towards 4-O-
methylbutein. Although we could not identify whether it is (R)- or
(S)-stereopreference – due to the lack of standard compounds –
we speculate that CHIera-Mut11 is very likely to have (S)-
stereoselectivity for 4-O-methylbutein, referring to the same B-
ring structure of 4-O-methylbutein and hesperetin and their similar
chiral-HPLC results. These results show that the previously
assumed degradation approach of (S)-naringenin through
chalcone, (R)-naringenin, and dihydrochalcone in bacterial
(Scheme 1b)[9] is most likely incorrect. Since the natural active
flavanones are all in the (S)-configuration, these bacterial-derived
CHIs with various substrate regioselectivities provide a diverse
toolkit of enzymes to replace the plant CHIs for the heterologous
synthesis of (S)-flavanones, also keeping in mind that the
bacterial CHIs are much easier to express recombinantly.
Therefore, we have used CHIera, CHIera-Mut5 and CHIera-Mut11 as
biocatalysts and achieved the enzymatic preparative scale
synthesis of naringenin, eriodictyol, homoeriodictyol, hesperetin,
and 7,3'-dihydroxy-4'-methoxyflavanone with yields of 85-100%,
respectively.
[9]
A. Braune, M. Gutschow, M. Blaut, Appl. Environ. Microb. 2019, 85.
[10] a) H. Schneider, M. Blaut, Arch. Microbiol. 2000, 173, 71-75; b) M.
Blaut, L. Schoefer, A. Braune, Int. J. Vitam. Nutr. Res. 2003, 73, 79-87.
[11] C. Herles, A. Braune, M. Blaut, Arch. Microbiol. 2004, 181, 428-434.
[12] M. Gall, M. Thomsen, C. Peters, I. V. Pavlidis, P. Jonczyk, P. P.
Grünert, S. Beutel, T. Scheper, E. Gross, M. Backes, T. Geißler, J. P.
Ley, J. M. Hilmer, G. Krammer, G. J. Palm, W. Hinrichs, U. T.
Bornscheuer, Angew. Chem. Int. Ed. 2014, 53, 1439-1442; Angew.
Chem. 2014, 126, 1463-1466.
[13] M. Thomsen, A. Tuukkanen, J. Dickerhoff, G. J. Palm, H. Kratzat, D. I.
Svergun, K. Weisz, U. T. Bornscheuer, W. Hinrichs, Acta. Crystallogr. D
Biol. Crystallogr. 2015, 71, 907-917.
[14] J. B. Mitchell, Curr. Opin. Struct. Biol. 2017, 47, 151-156.
[15] A. Waterhouse, M. Bertoni, S. Bienert, G. Studer, G. Tauriello, R.
Gumienny, F. T. Heer, T. A. P. de Beer, C. Rempfer, L. Bordoli, R.
Lepore, T. Schwede, Nucleic Acids Res. 2018, 46, W296-W303.
In summary, we successfully identified novel bacterial CHI-
like proteins from Genbank using the SSFE strategy and
confirmed them to have CHI activity. Several wild-type CHIs as
well the designed variants show high activity towards several
chalcones. Thus, the SSFE strategy has been demonstrated as a
useful tool to mine and improve novel and useful candidate
enzymes. Finally, we confirmed that bacterial CHIs have (S)-
stereopreference, which provides an alternative biocatalytic
pathway for the synthesis of (S)-flavanones with high yields.
Acknowledgements
This work was supported by the European Union’s Horizon 2020
Research and Innovation Programme under Grant Agreement no.
814650 for the project SynBio4Flav.
5
This article is protected by copyright. All rights reserved.